June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Evidence of clonal expansion among vitreous-derived T-cells in birdshot chorioretinopathy: A single cell profiling-based molecular case study
Author Affiliations & Notes
  • Wen Fury
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Sunil K Srivastava
    Cleveland Clinic, Cleveland, Ohio, United States
  • Charles Miller
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Christina Adler
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Sumit Sharma
    Cleveland Clinic, Cleveland, Ohio, United States
  • Kimberly Baynes
    Cleveland Clinic, Cleveland, Ohio, United States
  • Ashley Lowe
    Cleveland Clinic, Cleveland, Ohio, United States
  • Danielle X Burton
    Cleveland Clinic, Cleveland, Ohio, United States
  • Bolisa Hang
    Cleveland Clinic, Cleveland, Ohio, United States
  • Peter Kaiser
    Cleveland Clinic, Cleveland, Ohio, United States
  • Santiago Patricio Mendez Huergo
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Raquel Deering
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Min Ni
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Yi Wei
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Mickey Atwal
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Johnathan Weyne
    Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
  • Footnotes
    Commercial Relationships   Wen Fury Regeneron, Code E (Employment); Sunil Srivastava Novartis, Code C (Consultant/Contractor), Regeneron, Code C (Consultant/Contractor), Bausch and Lomb, Code C (Consultant/Contractor), Eyepoint, Code C (Consultant/Contractor), Eyevensys, Code C (Consultant/Contractor), Abbvie, Code C (Consultant/Contractor), Eyepoint, Code F (Financial Support), Regeneron, Code F (Financial Support); Charles Miller Regeneron, Code E (Employment); Christina Adler Regeneron, Code E (Employment); Sumit Sharma AbbVie, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Eyepoint, Code C (Consultant/Contractor), Clearside, Code C (Consultant/Contractor), Bausch and Lomb, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor), Regeneron, Code C (Consultant/Contractor), regenxbio, Code C (Consultant/Contractor); Kimberly Baynes None; Ashley Lowe None; Danielle Burton None; Bolisa Hang None; Peter Kaiser None; Santiago Mendez Huergo Regeneron, Code E (Employment); Raquel Deering Regeneron, Code E (Employment); Min Ni Regeneron, Code E (Employment); Yi Wei Regeneron, Code E (Employment); Mickey Atwal Regeneron, Code E (Employment); Johnathan Weyne Regeneron, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 429. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wen Fury, Sunil K Srivastava, Charles Miller, Christina Adler, Sumit Sharma, Kimberly Baynes, Ashley Lowe, Danielle X Burton, Bolisa Hang, Peter Kaiser, Santiago Patricio Mendez Huergo, Raquel Deering, Min Ni, Yi Wei, Mickey Atwal, Johnathan Weyne; Evidence of clonal expansion among vitreous-derived T-cells in birdshot chorioretinopathy: A single cell profiling-based molecular case study. Invest. Ophthalmol. Vis. Sci. 2023;64(8):429.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Birdshot chorioretinopathy (BSCR) is a rare autoimmune posterior uveitis with a significant association with the HLA-A29 genotype. T cell infiltration has been observed in the vitreous of BSCR patients. However, no expanded T cell receptor (TCR) clones with paired TCR alpha chain (TRA) and TCR beta chain (TRB) information and associated T cell phenotype have been reported. Here we report single cell-based profiling results from a BSCR patient.

Methods : A single patient with history of BSCR, diagnosed by clinical presentation and positive HLA-A29 testing was included in this IRB approved prospective study. The vitreous sample was collected during fluocinolone acetonide implantation with pars plana vitrectomy. 10X Genomics scSEQ platform and Illumina NextSeq500 were used for 5’ mRNA and V(D)J sequencing using the standard protocol, except that TRA and TRB were further enriched using primers designed in-house. Cell Ranger (v2.2.0) and Seurat (v4) were used for data processing and analysis. GRCh38 and germline segment V(D)J from IMGT were used as references.

Results : Clustering analysis revealed 107 droplets in the CD3+ cluster and 313 in the CD68+ cluster. Among the 63 CD3+ droplets with both TRA and TRB information, highly skewed TCR clonalities were found: 1 clonotype shared by 16 droplets, 2 shared by 3 droplets each, 5 shared by 2 droplets each, and 31 singletons. Two of the topmost expanded clonotypes were CD8A+, none were CD4+, and all were granzyme positive and/or NKG7+, suggesting a cytotoxic phenotype.

Conclusions : Using single cell mRNA and V(D)J sequencing, we have identified expanded TCR clones with paired TRA and TRB information from the vitreous of a BSCR patient. The TCR clonotypes were highly skewed towards a cytotoxic T cell phenotype. Otherwise, ~75% were CD68+ myeloid cells. This suggests a role for CD8+ T cells in the pathogenesis of BSCR. Whether a similar CD8+ T cell repertoire can be identified in the systemic circulation, engages peptide-bound HLA-A29, and/or if their presence in the vitreous correlate with disease activity will all be relevant to address in future studies.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×